Bayzed Health Reports Stable Share Capital Structure in March 2026 Monthly Return

Bulletin Express04-02

Bayzed Health Group Inc. submitted its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The filing was lodged with Hong Kong Exchanges and Clearing Limited on 8 April 2026.

Authorised Capital • The company’s authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001, representing total authorised capital of USD 50,000.

Issued Shares and Treasury Position • Issued ordinary shares stood unchanged at 1.32 billion. • No treasury shares were held or created, keeping total issued shares at 1.32 billion.

Public Float Compliance • Bayzed Health confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 March 2026.

Share Option Scheme Activity • The post-IPO share option scheme adopted on 8 August 2023 (amended 9 June 2025) reported zero outstanding, granted, or exercised options, resulting in no new share issuances or fund inflows.

Other Equity Instruments • The company reported no warrants, convertibles, or other equity-linked agreements, and recorded no other movements in issued or treasury shares.

The absence of equity movements underscores a stable capital structure for Bayzed Health in March 2026, with full regulatory compliance affirmed in the latest filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122689015?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122689015","market":"hk","top_or_hot":-1,"title":"Bayzed Health Reports Stable Share Capital Structure in March 2026 Monthly Return","media":"Bulletin Express","content":"<p>Bayzed Health Group Inc. submitted its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The filing was lodged with Hong Kong Exchanges and Clearing Limited on 8 April 2026.</p>\n<p>Authorised Capital  \n• The company’s authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001, representing total authorised capital of USD 50,000.</p>\n<p>Issued Shares and Treasury Position  \n• Issued ordinary shares stood unchanged at 1.32 billion.  \n• No treasury shares were held or created, keeping total issued shares at 1.32 billion.</p>\n<p>Public Float Compliance  \n• Bayzed Health confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 March 2026.</p>\n<p>Share Option Scheme Activity  \n• The post-IPO share option scheme adopted on 8 August 2023 (amended 9 June 2025) reported zero outstanding, granted, or exercised options, resulting in no new share issuances or fund inflows.</p>\n<p>Other Equity Instruments  \n• The company reported no warrants, convertibles, or other equity-linked agreements, and recorded no other movements in issued or treasury shares.</p>\n<p>The absence of equity movements underscores a stable capital structure for Bayzed Health in March 2026, with full regulatory compliance affirmed in the latest filing.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayzed Health Reports Stable Share Capital Structure in March 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayzed Health Reports Stable Share Capital Structure in March 2026 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bayzed Health Group Inc. submitted its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The filing was lodged with Hong Kong Exchanges and Clearing Limited on 8 April 2026.</p>\n<p>Authorised Capital  \n• The company’s authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001, representing total authorised capital of USD 50,000.</p>\n<p>Issued Shares and Treasury Position  \n• Issued ordinary shares stood unchanged at 1.32 billion.  \n• No treasury shares were held or created, keeping total issued shares at 1.32 billion.</p>\n<p>Public Float Compliance  \n• Bayzed Health confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 March 2026.</p>\n<p>Share Option Scheme Activity  \n• The post-IPO share option scheme adopted on 8 August 2023 (amended 9 June 2025) reported zero outstanding, granted, or exercised options, resulting in no new share issuances or fund inflows.</p>\n<p>Other Equity Instruments  \n• The company reported no warrants, convertibles, or other equity-linked agreements, and recorded no other movements in issued or treasury shares.</p>\n<p>The absence of equity movements underscores a stable capital structure for Bayzed Health in March 2026, with full regulatory compliance affirmed in the latest filing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02609","symbol_name":"佰泽医疗","start_time":0,"source_url":"","article_id":"1122689015","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122689015","pubTimestamp":1775120710,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Bayzed Health Group Inc. submitted its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The filing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02609":"佰泽医疗"},"translate_title":"Bayzed Health报告2026年3月股本结构稳定月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02609":1},"content_text":"Bayzed Health Group Inc. submitted its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either authorised or issued share capital during the month. The filing was lodged with Hong Kong Exchanges and Clearing Limited on 8 April 2026.\nAuthorised Capital  \n• The company’s authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001, representing total authorised capital of USD 50,000.\nIssued Shares and Treasury Position  \n• Issued ordinary shares stood unchanged at 1.32 billion.  \n• No treasury shares were held or created, keeping total issued shares at 1.32 billion.\nPublic Float Compliance  \n• Bayzed Health confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 March 2026.\nShare Option Scheme Activity  \n• The post-IPO share option scheme adopted on 8 August 2023 (amended 9 June 2025) reported zero outstanding, granted, or exercised options, resulting in no new share issuances or fund inflows.\nOther Equity Instruments  \n• The company reported no warrants, convertibles, or other equity-linked agreements, and recorded no other movements in issued or treasury shares.\nThe absence of equity movements underscores a stable capital structure for Bayzed Health in March 2026, with full regulatory compliance affirmed in the latest filing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122689015","isCrawlerRequest":true}